About Ravi Jain, Ph.D.
Ravi Jain began his education at the University of California, Davis, and received his PhD in bioinformatics from University of California, Los Angeles. He started his career designing drugs at Ionis Pharmaceuticals, an antisense drug development company, where his efforts received 12 patents.
Ravi has a background in microbial bioinformatics and was the co-founder and President of cBio, a bioinformatics/software development consulting firm. Under his leadership, cBio was awarded ‘Top-50 San Jose Business Journal’s Fastest Growing Private Company’ in 2010, 2011 & 2012.
Other experience includes serving as Managing Director of the UC Santa Cruz Genomics Institute. He then served as CSO of Hemostemix, where he ran a Phase II trial on stem cell therapeutics for vascular diseases. He concurrently serves as CEO of Domina Therapeutics, a spin-out of Dr. Evan Snyder’s SRF-supported work.
